Long-Term Liabilities to Equity: Establishment Labs Inc (ESTA)

Official company branding of Establishment Labs Inc (ESTA)

This market valuation chart helps illustrate the growth trajectory of Establishment Labs (ESTA), a leader in the breast implant niche implementing RFID tags and nanotechnology for patient safety. Financial stability is based on excess liquidity and high-margin streams, with the indicator standing at 12.37. However, the business relies on volatile demand during crises and strict regulation in China and the US.

Motiva (ESTA): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026

Comprehensive metric breakdowns and analytics for Establishment Labs (ESTA)

- price and consensus price forecast:
Market Chart Establishment Labs Corp|ESTA - Price Target Chart
- market capitalization data:
Market Valuation Establishment Labs Holdings Inc.|ESTA - Enterprise Value
- book capitalization data:
Net Asset Value per Share Establishment Labs|ESTA - Book Capitalization|Market Cap to Net Assets Ratio establishmentlabs.com|ESTA - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Establishment Labs|ESTA - Long-Term Debt to Capital|Short-Term Debt to Capital establishmentlabs.com|ESTA - Company Debts|Debt to Book Capitalization Ratio Establishment Labs Holdings Inc.|ESTA - Company Long-Term Debts|Short-Term Debt Volume Establishment Labs
Comprehensive company analysis:ESTA, Establishment Labs Corp
Core merchandise of Establishment Labs

This indicator assesses financial stability by comparing liabilities with a maturity of over one year against the company's total equity. By analyzing the long-term debt-to-equity ratio, an investor can discern the dependence of debt financing on the market value of Establishment Labs (ESTA) shares, which is critical for evaluating management's resources during the technological displacement of competitors in the medical aesthetics sector.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital AORT|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity Integra LifeSciences Corp (IART)|Long-Term Debt to Capital BBNX|IRMD - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio Embecta Corp.|TNDM - Long-Term Liabilities to Equity|Long-Term Debt to Capital AXGN|SI-BONE Inc (SIBN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital Orthofix International (OFIX)|Long-Term Debt to Capital Ratio Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient TMCI (treace.com)|Strata Critical Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Carlsmed, Inc. CARL|RXST (RxSight Corp) - Long-Term Debt to Capital|CLPT - Long-Term Liabilities to Capital|Long-Term Debt to Capital Stereotaxis, Inc.|neurostar.com (STIM) - Long-Term Debt to Capital Ratio|SGHT: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Orchestra BioMed Inc.|Long-Term Debt to Capital ANIK (Anika Therapeutics)|Long-Term Debt to Equity Ratio InspireMD Inc. (NSPR)|Long-Term Debt to Capital ZJYL (Jin Medical)|Vivani Medical Inc - Long-Term Debt to Capital|XTNT - Long-Term Debt to Equity|NeuroOne (NMTC) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio modular-medical.com MODD|Myomo Inc (MYO) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital COCH (Envoy Medical, Inc.)|Long-Term Liabilities to Capital VVOS|NVNO: Long-Term Debt to Equity|Long-Term Indebtedness to Equity sintx.com SINT|Long-Term Debt to Equity Ratio TNON (Tenon Medical, Inc)|Long-Term Debt to Capital Lifeward Ltd. LFWD|Long-Term Debt to Capital AMIX (Autonomix)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)